Skip to content
HomeLatest newsJohnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.
JNJ-Earns-Spot-on-Fortunes-2021-Change-the-World-List-lede-B.jpg

Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.

The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.

This week Fortune included Johnson & Johnson on its 2021 Change the World list, which spotlights companies across the globe that have leveraged their core business strategies to drive positive social impact.

While the vaccine makers on last year’s list were recognized for their unprecedented collaboration on fighting the coronavirus, this year’s list highlights those that are helping expand access to COVID-19 vaccines around the world. Johnson & Johnson is honored to be included for its efforts to make available its Janssen COVID-19 vaccine, for which it received Emergency Use Authorization from the U.S. Food and Drug Administration in February.

To compile the prestigious list, Fortune evaluated companies on the impact they’ve made in addressing one or more of society’s problems, the business results of those actions and the level of innovation involved. Also taken into consideration: how essential the company’s initiative was to its overall business strategy.

A commitment to social responsibility and innovation

For more than a century, Johnson & Johnson has relied on a core set of values to guide every aspect of the way it does business.

When COVID-19 hit, the company was able to respond to the once-in-a-lifetime global health challenge by harnessing its capabilities, scientific expertise, global partnerships and experience in helping fight pandemics for over a century—and its 130,000-plus employees around the world mobilized with urgency to address the critical needs of families, communities and healthcare providers.

That sort of innovation and a commitment to social responsibility provide the foundation for Our Credo, the company mission statement that compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.

This isn’t the first time Fortune has recognized Johnson & Johnson. Earlier this month, Jennifer Taubert, the company’s Executive Vice President and Worldwide Chairman, Pharmaceuticals, was named to Fortune’s 2021 list of the Most Powerful Women in Business for the sixth consecutive year. In June, the company landed the #4 spot on Fortune’s Return on Leadership List, a ranking of the top 100 companies on the Fortune 500 list. And early this year, the brand included Johnson & Johnson among the World’s Most Admired Companies, placing it at #1 in the Pharmaceutical category worldwide for the eighth consecutive year.

Johnson & Johnson is proud to be recognized again.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.